Globus Medical shares rise following EU approval of imaging system
Source Summary
Globus Medical's stock price increased following European Union regulatory approval for one of its imaging systems. The approval represents a regulatory milestone for the medical device company's product portfolio.
Why it matters
EU regulatory approval expands the company's addressable market and validates its imaging technology for European medical institutions.
